SCHEMBL6166098

SCHEMBL6166098

[c]1nc(Cc2ccccn2)c[nH]1

nearest known ligand 0.46

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
HRH3 Q9Y5N1 2/20 0.44
HRH4 Q9H3N8 1/20 0.44
L3MBTL1 Q9Y468 1/20 0.42
HRH1 P35367 1/20 0.40
TSHR P16473 1/20 0.40
LMNA P02545 1/20 0.40
TAAR1 Q96RJ0 1/20 0.40
ALDH1A1 P00352 1/20 0.40
ALOX15 P16050 1/20 0.40
SMN1; SMN2 Q16637 2/20 0.39
MAPT P10636 1/20 0.39
LIN28A Q9H9Z2 1/20 0.39
TDP1 Q9NUW8 1/20 0.39
ASIC3 Q9UHC3 1/20 0.39
MAOA P21397 1/20 0.37
MAOB P27338 1/20 0.37
PNP P00491 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29830938 0.78 L3MBTL1 (0.59) HRH3HRH4L3MBTL1HRH1TSHR
SCHEMBL41191 0.78 L3MBTL1 (0.59) HRH3HRH4L3MBTL1HRH1TSHR
Hydrochloric Acid SCHEMBL10884973 0.76 L3MBTL1 (0.57) HRH3HRH4L3MBTL1HRH1LMNA
Bromide SCHEMBL6114859 0.76 L3MBTL1 (0.57) HRH3HRH4L3MBTL1HRH1TSHR
SCHEMBL29715188 0.76 L3MBTL1 (0.57) HRH3HRH4L3MBTL1HRH1TSHR
Ammonia Solution, Strong SCHEMBL6176560 0.76 L3MBTL1 (0.57) HRH3HRH4L3MBTL1HRH1TSHR
SCHEMBL4938201 0.76 L3MBTL1 (0.57) HRH3HRH4L3MBTL1HRH1TSHR
SCHEMBL4938207 0.76 L3MBTL1 (0.57) HRH3HRH4L3MBTL1HRH1TSHR
SCHEMBL1239982 0.76 CALM1 (0.42) HRH3L3MBTL1TSHRLMNATAAR1
SCHEMBL5757688 0.75 PARP10 (0.43) HRH1LMNAALDH1A1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1417177-A4 ACYLSEMICARBAZIDES AS CYCLIN DEPENDENT KINASE INHIBITORS USEFUL AS ANTI-CANCER AND ANTI-PROLIFERATIVE AGENTS BRISTOL MYERS SQUIBB PHARMA CO (US) 2005-10-19 EP disclosed
CN-1553900-A Acylsemicarbazides as cyclin dependent kinase inhibitors useful as anti-cancer and anti-proliferative agents ��ʱ��ʩ����ҩ��˾ 2004-12-08 CN disclosed
EP-1417177-A2 ACYLSEMICARBAZIDES AS CYCLIN DEPENDENT KINASE INHIBITORS USEFUL AS ANTI-CANCER AND ANTI-PROLIFERATIVE AGENTS Bristol-Myers Squibb Pharma Company (US) 2004-05-12 EP disclosed
WO-2003007883-A2 ACYLSEMICARBAZIDES AS CYCLIN DEPENDENT KINASE INHIBITORS USEFUL AS ANTI-CANCER AND ANTI-PROLIFERATIVE AGENTS BRISTOL-MYERS SQUIBB PHARMA COMPANY (US) 2003-01-30 WO disclosed
EP-1071668-A1 5-AMINOINDENO(1,2-C)PYRAZOL-4-ONES AS ANTI-CANCER AND ANTI-PROLIFERATIVE AGENTS Du Pont Pharmaceuticals Company (US) 2001-01-31 EP disclosed
WO-1999054308-A1 5-AMINOINDENO(1,2-C)PYRAZOL-4-ONES AS ANTI-CANCER AND ANTI-PROLIFERATIVE AGENTS DU PONT PHARMACEUTICALS COMPANY (US) 1999-10-28 WO disclosed